General Information of the Protein
Protein ID
PT05076
Protein Name
Replicase polyprotein 1ab
Secondarily
Protein Name
ORF1ab polyprotein
Leader protein
Non-structural protein 1
p65 homolog
Non-structural protein 3
PL2-PRO
Papain-like proteinase
Main protease
Non-structural protein 5
SARS coronavirus main proteinase
Non-structural protein 9
RNA-capping enzyme subunit nsp9
Growth factor-like peptide
Non-structural protein 12
Non-structural protein 13
Non-structural protein 14
Proofreading exoribonuclease nsp14
NendoU
Non-structural protein 15
Non-structural protein 16
Gene Name
REP
Secondarily
Gene Name
1a-1b
Sequence
MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELGTDPYEDFQENWNTKHSSGVTRELMRELNGGAYTRYVDNNFCGPDGYPLECIKDLLARAGKASCTLSEQLDFIDTKRGVYCCREHEHEIAWYTERSEKSYELQTPFEIKLAKKFDTFNGECPNFVFPLNSIIKTIQPRVEKKKLDGFMGRIRSVYPVASPNECNQMCLSTLMKCDHCGETSWQTGDFVKATCEFCGTENLTKEGATTCGYLPQNAVVKIYCPACHNSEVGPEHSLAEYHNESGLKTILRKGGRTIAFGGCVFSYVGCHNKCAYWVPRASANIGCNHTGVVGEGSEGLNDNLLEILQKEKVNINIVGDFKLNEEIAIILASFSASTSAFVETVKGLDYKAFKQIVESCGNFKVTKGKAKKGAWNIGEQKSILSPLYAFASEAARVVRSIFSRTLETAQNSVRVLQKAAITILDGISQYSLRLIDAMMFTSDLATNNLVVMAYITGGVVQLTSQWLTNIFGTVYEKLKPVLDWLEEKFKEGVEFLRDGWEIVKFISTCACEIVGGQIVTCAKEIKESVQTFFKLVNKFLALCADSIIIGGAKLKALNLGETFVTHSKGLYRKCVKSREETGLLMPLKAPKEIIFLEGETLPTEVLTEEVVLKTGDLQPLEQPTSEAVEAPLVGTPVCINGLMLLEIKDTEKYCALAPNMMVTNNTFTLKGGAPTKVTFGDDTVIEVQGYKSVNITFELDERIDKVLNEKCSAYTVELGTEVNEFACVVADAVIKTLQPVSELLTPLGIDLDEWSMATYYLFDESGEFKLASHMYCSFYPPDEDEEEGDCEEEEFEPSTQYEYGTEDDYQGKPLEFGATSAALQPEEEQEEDWLDDDSQQTVGQQDGSEDNQTTTIQTIVEVQPQLEMELTPVVQTIEVNSFSGYLKLTDNVYIKNADIVEEAKKVKPTVVVNAANVYLKHGGGVAGALNKATNNAMQVESDDYIATNGPLKVGGSCVLSGHNLAKHCLHVVGPNVNKGEDIQLLKSAYENFNQHEVLLAPLLSAGIFGADPIHSLRVCVDTVRTNVYLAVFDKNLYDKLVSSFLEMKSEKQVEQKIAEIPKEEVKPFITESKPSVEQRKQDDKKIKACVEEVTTTLEETKFLTENLLLYIDINGNLHPDSATLVSDIDITFLKKDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPGQGLNGYTVEEAKTVLKKCKSAFYILPSIISNEKQEILGTVSWNLREMLAHAEETRKLMPVCVETKAIVSTIQRKYKGIKIQEGVVDYGARFYFYTSKTTVASLINTLNDLNETLVTMPLGYVTHGLNLEEAARYMRSLKVPATVSVSSPDAVTAYNGYLTSSSKTPEEHFIETISLAGSYKDWSYSGQSTQLGIEFLKRGDKSVYYTSNPTTFHLDGEVITFDNLKTLLSLREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPVTYKLDGVVCTEIDPKLDNYYKKDNSYFTEQPIDLVPNQPYPNASFDNFKFVCDNIKFADDLNQLTGYKKPASRELKVTFFPDLNGDVVAIDYKHYTPSFKKGAKLLHKPIVWHVNNATNKATYKPNTWCIRCLWSTKPVETSNSFDVLKSEDAQGMDNLACEDLKPVSEEVVENPTIQKDVLECNVKTTEVVGDIILKPANNSLKITEEVGHTDLMAAYVDNSSLTIKKPNELSRVLGLKTLATHGLAAVNSVPWDTIANYAKPFLNKVVSTTTNIVTRCLNRVCTNYMPYFFTLLLQLCTFTRSTNSRIKASMPTTIAKNTVKSVGKFCLEASFNYLKSPNFSKLINIIIWFLLLSVCLGSLIYSTAALGVLMSNLGMPSYCTGYREGYLNSTNVTIATYCTGSIPCSVCLSGLDSLDTYPSLETIQITISSFKWDLTAFGLVAEWFLAYILFTRFFYVLGLAAIMQLFFSYFAVHFISNSWLMWLIINLVQMAPISAMVRMYIFFASFYYVWKSYVHVVDGCNSSTCMMCYKRNRATRVECTTIVNGVRRSFYVYANGGKGFCKLHNWNCVNCDTFCAGSTFISDEVARDLSLQFKRPINPTDQSSYIVDSVTVKNGSIHLYFDKAGQKTYERHSLSHFVNLDNLRANNTKGSLPINVIVFDGKSKCEESSAKSASVYYSQLMCQPILLLDQALVSDVGDSAEVAVKMFDAYVNTFSSTFNVPMEKLKTLVATAEAELAKNVSLDNVLSTFISAARQGFVDSDVETKDVVECLKLSHQSDIEVTGDSCNNYMLTYNKVENMTPRDLGACIDCSARHINAQVAKSHNIALIWNVKDFMSLSEQLRKQIRSAAKKNNLPFKLTCATTRQVVNVVTTKIALKGGKIVNNWLKQLIKVTLVFLFVAAIFYLITPVHVMSKHTDFSSEIIGYKAIDGGVTRDIASTDTCFANKHADFDTWFSQRGGSYTNDKACPLIAAVITREVGFVVPGLPGTILRTTNGDFLHFLPRVFSAVGNICYTPSKLIEYTDFATSACVLAAECTIFKDASGKPVPYCYDTNVLEGSVAYESLRPDTRYVLMDGSIIQFPNTYLEGSVRVVTTFDSEYCRHGTCERSEAGVCVSTSGRWVLNNDYYRSLPGVFCGVDAVNLLTNMFTPLIQPIGALDISASIVAGGIVAIVVTCLAYYFMRFRRAFGEYSHVVAFNTLLFLMSFTVLCLTPVYSFLPGVYSVIYLYLTFYLTNDVSFLAHIQWMVMFTPLVPFWITIAYIICISTKHFYWFFSNYLKRRVVFNGVSFSTFEEAALCTFLLNKEMYLKLRSDVLLPLTQYNRYLALYNKYKYFSGAMDTTSYREAACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQSAVKRTIKGTHHWLLLTILTSLLVLVQSTQWSLFFFLYENAFLPFAMGIIAMSAFAMMFVKHKHAFLCLFLLPSLATVAYFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYDDGARRVWTLMNVLTLVYKVYYGNALDQAISMWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVYCFLGYFCTCYFGLFCLLNRYFRLTLGVYDYLVSTQEFRYMNSQGLLPPKNSIDAFKLNIKLLGVGGKPCIKVATVQSKMSDVKCTSVVLLSVLQQLRVESSSKLWAQCVQLHNDILLAKDTTEAFEKMVSLLSVLLSMQGAVDINKLCEEMLDNRATLQAIASEFSSLPSYAAFATAQEAYEQAVANGDSEVVLKKLKKSLNVAKSEFDRDAAMQRKLEKMADQAMTQMYKQARSEDKRAKVTSAMQTMLFTMLRKLDNDALNNIINNARDGCVPLNIIPLTTAAKLMVVIPDYNTYKNTCDGTTFTYASALWEIQQVVDADSKIVQLSEISMDNSPNLAWPLIVTALRANSAVKLQNNELSPVALRQMSCAAGTTQTACTDDNALAYYNTTKGGRFVLALLSDLQDLKWARFPKSDGTGTIYTELEPPCRFVTDTPKGPKVKYLYFIKGLNNLNRGMVLGSLAATVRLQAGNATEVPANSTVLSFCAFAVDAAKAYKDYLASGGQPITNCVKMLCTHTGTGQAITVTPEANMDQESFGGASCCLYCRCHIDHPNPKGFCDLKGKYVQIPTTCANDPVGFTLKNTVCTVCGMWKGYGCSCDQLREPMLQSADAQSFLNRVCGVSAARLTPCGTGTSTDVVYRAFDIYNDKVAGFAKFLKTNCCRFQEKDEDDNLIDSYFVVKRHTFSNYQHEETIYNLLKDCPAVAKHDFFKFRIDGDMVPHISRQRLTKYTMADLVYALRHFDEGNCDTLKEILVTYNCCDDDYFNKKDWYDFVENPDILRVYANLGERVRQALLKTVQFCDAMRNAGIVGVLTLDNQDLNGNWYDFGDFIQTTPGSGVPVVDSYYSLLMPILTLTRALTAESHVDTDLTKPYIKWDLLKYDFTEERLKLFDRYFKYWDQTYHPNCVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHFRELGVVHNQDVNLHSSRLSFKELLVYAADPAMHAASGNLLLDKRTTCFSVAALTNNVAFQTVKPGNFNKDFYDFAVSKGFFKEGSSVELKHFFFAQDGNAAISDYDYYRYNLPTMCDIRQLLFVVEVVDKYFDCYDGGCINANQVIVNNLDKSAGFPFNKWGKARLYYDSMSYEDQDALFAYTKRNVIPTITQMNLKYAISAKNRARTVAGVSICSTMTNRQFHQKLLKSIAATRGATVVIGTSKFYGGWHNMLKTVYSDVENPHLMGWDYPKCDRAMPNMLRIMASLVLARKHTTCCSLSHRFYRLANECAQVLSEMVMCGGSLYVKPGGTSSGDATTAYANSVFNICQAVTANVNALLSTDGNKIADKYVRNLQHRLYECLYRNRDVDTDFVNEFYAYLRKHFSMMILSDDAVVCFNSTYASQGLVASIKNFKSVLYYQNNVFMSEAKCWTETDLTKGPHEFCSQHTMLVKQGDDYVYLPYPDPSRILGAGCFVDDIVKTDGTLMIERFVSLAIDAYPLTKHPNQEYADVFHLYLQYIRKLHDELTGHMLDMYSVMLTNDNTSRYWEPEFYEAMYTPHTVLQAVGACVLCNSQTSLRCGACIRRPFLCCKCCYDHVISTSHKLVLSVNPYVCNAPGCDVTDVTQLYLGGMSYYCKSHKPPISFPLCANGQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYILANTCTERLKLFAAETLKATEETFKLSYGIATVREVLSDRELHLSWEVGKPRPPLNRNYVFTGYRVTKNSKVQIGEYTFEKGDYGDAVVYRGTTTYKLNVGDYFVLTSHTVMPLSAPTLVPQEHYVRITGLYPTLNISDEFSSNVANYQKVGMQKYSTLQGPPGTGKSHFAIGLALYYPSARIVYTACSHAAVDALCEKALKYLPIDKCSRIIPARARVECFDKFKVNSTLEQYVFCTVNALPETTADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTLEPEYFNSVCRLMKTIGPDMFLGTCRRCPAEIVDTVSALVYDNKLKAHKDKSAQCFKMFYKGVITHDVSSAINRPQIGVVREFLTRNPAWRKAVFISPYNSQNAVASKILGLPTQTVDSSQGSEYDYVIFTQTTETAHSCNVNRFNVAITRAKVGILCIMSDRDLYDKLQFTSLEIPRRNVATLQAENVTGLFKDCSKVITGLHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNGYPNMFITREEAIRHVRAWIGFDVEGCHATREAVGTNLPLQLGFSTGVNLVAVPTGYVDTPNNTDFSRVSAKPPPGDQFKHLIPLMYKGLPWNVVRIKIVQMLSDTLKNLSDRVVFVLWAHGFELTSMKYFVKIGPERTCCLCDRRATCFSTASDTYACWHHSIGFDYVYNPFMIDVQQWGFTGNLQSNHDLYCQVHGNAHVASCDAIMTRCLAVHECFVKRVDWTIEYPIIGDELKINAACRKVQHMVVKAALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSYATHSDKFTDGVCLFWNCNVDRYPANSIVCRFDTRVLSNLNLPGCDGGSLYVNKHAFHTPAFDKSAFVNLKQLPFFYYSDSPCESHGKQVVSDIDYVPLKSATCITRCNLGGAVCRHHANEYRLYLDAYNMMISAGFSLWVYKQFDTYNLWNTFTRLQSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQSSQAWQPGVAMPNLYKMQRMLLEKCDLQNYGDSATLPKGIMMNVAKYTQLCQYLNTLTLAVPYNMRVIHFGAGSDKGVAPGTAVLRQWLPTGTLLVDSDLNDFVSDADSTLIGDCATVHTANKWDLIISDMYDPKTKNVTKENDSKEGFFTYICGFIQQKLALGGSVAIKITEHSWNADLYKLMGHFAWWTAFVTNVNASSSEAFLIGCNYLGKPREQIDGYVMHANYIFWRNTNPIQLSSYSLFDMSKFPLKLRGTAVMSLKEGQINDMILSLLSKGRLIIRENNRVVISSDVLVNN
    Show/Hide
Organism
Severe acute respiratory syndrome coronavirus 2, 2019-nCoV, SARS-CoV-2
Protein Classification
Enzyme
>
Transferase
Function
Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.
    Show/Hide
Uniprot ID
P0DTD1
Subcellular Location
Host cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000025 , HEK-293T
Compound ID Compound Name Compound Formula
CP0534401
2-[(4-bromo-1H-indol-3-yl)sulfanyl]-N-[(2-ethoxyphenyl)methyl]-N-methoxyacetamide
   Show/Hide
C20H21BrN2O3S
 2
1
IC50 = 1110 nM
   TI
   LI
   LO
   TS
2
IC50 = 1890 nM
   TI
   LI
   LO
   TS
CP0571128
Remdesivir
   Show/Hide
C27H35N6O8P
 3
1
IC50 = 1190 nM
   TI
   LI
   LO
   TS
2
IC50 = 1560 nM
   TI
   LI
   LO
   TS
3
IC50 = 3110 nM
   TI
   LI
   LO
   TS
CP0419996
N-[(2-methoxyphenyl)methyl]-2-[(7-phenyl-1H-indol-3-yl)sulfanyl]acetamide
   Show/Hide
C24H22N2O2S
 2
1
IC50 = 1650 nM
   TI
   LI
   LO
   TS
2
IC50 = 2180 nM
   TI
   LI
   LO
   TS
CP0494253
N,N-dibenzyl-2-(1H-indol-3-ylsulfanyl)acetamide
   Show/Hide
C24H22N2OS
 2
1
IC50 = 3350 nM
   TI
   LI
   LO
   TS
2
IC50 = 4010 nM
   TI
   LI
   LO
   TS
CP0572638
N,N-dibenzyl-2-[(4-bromo-1H-indol-3-yl)sulfanyl]acetamide
   Show/Hide
C24H21BrN2OS
 2
1
IC50 = 3760 nM
   TI
   LI
   LO
   TS
2
IC50 = 3850 nM
   TI
   LI
   LO
   TS
CP0419988
N-benzyl-2-(1H-indol-3-ylsulfanyl)-N-methylacetamide
   Show/Hide
C18H18N2OS
 2
1
IC50 = 4550 nM
   TI
   LI
   LO
   TS
2
IC50 = 5370 nM
   TI
   LI
   LO
   TS
CP0575097
2-[(7-bromo-1H-indol-3-yl)sulfanyl]-N-[(3,4-dichlorophenyl)methyl]acetamide
   Show/Hide
C17H13BrCl2N2OS
 1
1
IC50 = 4550 nM
   TI
   LI
   LO
   TS
CP0553543
N-benzyl-2-[(4-bromo-1H-indol-3-yl)sulfanyl]-N-methylacetamide
   Show/Hide
C18H17BrN2OS
 1
1
IC50 = 4730 nM
   TI
   LI
   LO
   TS
CP0964129
(R)-2((1H-indol-3-yl)thio)-N-(1-phenylethyl)acetamide
   Show/Hide
C18H18N2OS
 1
1
IC50 = 6680 nM
   TI
   LI
   LO
   TS
CP0575096
N-benzyl-2-(1H-indol-3-ylsulfanyl)acetamide
   Show/Hide
C17H16N2OS
 1
1
IC50 = 6810 nM
   TI
   LI
   LO
   TS
CP0534400
N,N-dibenzyl-2-[(7-bromo-1H-indol-3-yl)sulfanyl]acetamide
   Show/Hide
C24H21BrN2OS
 1
1
IC50 = 7080 nM
   TI
   LI
   LO
   TS
CP0557978
2-[(7-bromo-1H-indol-3-yl)sulfanyl]-N-[(2-methoxyphenyl)methyl]acetamide
   Show/Hide
C18H17BrN2O2S
 1
1
IC50 = 7080 nM
   TI
   LI
   LO
   TS
CP0557977
2-[(4-bromo-1H-indol-3-yl)sulfanyl]-N-[(3,4-dichlorophenyl)methyl]acetamide
   Show/Hide
C17H13BrCl2N2OS
 1
1
IC50 = 7210 nM
   TI
   LI
   LO
   TS
CP0544153
N-[(3,4-dichlorophenyl)methyl]-2-(1-methylindol-3-yl)sulfanylacetamide
   Show/Hide
C18H16Cl2N2OS
 1
1
IC50 = 7500 nM
   TI
   LI
   LO
   TS
CP0559206
2-(1H-indol-3-ylsulfanyl)-N-[(2-methoxyphenyl)methyl]-N-methylacetamide
   Show/Hide
C19H20N2O2S
 1
1
IC50 = 7640 nM
   TI
   LI
   LO
   TS
CP0572637
2-(1H-indol-3-ylsulfanyl)-N-[[4-(trifluoromethyl)phenyl]methyl]acetamide
   Show/Hide
C18H15F3N2OS
 1
1
IC50 = 7940 nM
   TI
   LI
   LO
   TS
CP0548339
2-[(6-bromo-1H-indol-3-yl)sulfanyl]-N-[(3,4-dichlorophenyl)methyl]acetamide
   Show/Hide
C17H13BrCl2N2OS
 1
1
IC50 = 8710 nM
   TI
   LI
   LO
   TS
CP0573110
2-[(4-bromo-1H-indol-3-yl)sulfanyl]-N-[(2-methoxyphenyl)methyl]acetamide
   Show/Hide
C18H17BrN2O2S
 1
1
IC50 = 8710 nM
   TI
   LI
   LO
   TS
CP0534397
N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-2-(1-methylindol-3-yl)sulfanylacetamide
   Show/Hide
C22H27N3O2S
 1
1
IC50 = 8910 nM
   TI
   LI
   LO
   TS
CP0573183
N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-2-(1H-indol-3-ylsulfanyl)acetamide
   Show/Hide
C21H25N3O2S
 1
1
IC50 = 9080 nM
   TI
   LI
   LO
   TS
CP0534399
2-[(5-bromo-1H-indol-3-yl)sulfanyl]-N-[(3,4-dichlorophenyl)methyl]acetamide
   Show/Hide
C17H13BrCl2N2OS
 1
1
IC50 = 9770 nM
   TI
   LI
   LO
   TS
CP0559205
N-[(2-methoxyphenyl)methyl]-2-(1-methylindol-3-yl)sulfanylacetamide
   Show/Hide
C19H20N2O2S
 1
1
IC50 = 9820 nM
   TI
   LI
   LO
   TS
CP0419989
2-[(6-bromo-1H-indol-3-yl)sulfanyl]-N-[(2-methoxyphenyl)methyl]acetamide
   Show/Hide
C18H17BrN2O2S
 1
1
IC50 = 10010 nM
   TI
   LI
   LO
   TS
CP0573184
2-[(5-bromo-1H-indol-3-yl)sulfanyl]-N-[(2-methoxyphenyl)methyl]acetamide
   Show/Hide
C18H17BrN2O2S
 1
1
IC50 = 10720 nM
   TI
   LI
   LO
   TS
CP0548338
N,N-dibenzyl-2-(1-methylindol-3-yl)sulfanylacetamide
   Show/Hide
C25H24N2OS
 1
1
IC50 = 12300 nM
   TI
   LI
   LO
   TS
CP0546374
N-benzyl-2-[(7-bromo-1H-indol-3-yl)sulfanyl]-N-methylacetamide
   Show/Hide
C18H17BrN2OS
 1
1
IC50 = 20890 nM
   TI
   LI
   LO
   TS
CP0572636
N-benzyl-2-(1-methylindol-3-yl)sulfanylacetamide
   Show/Hide
C18H18N2OS
 1
1
IC50 = 26920 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0571038
benzyl N-[(2S,3R)-1-[[(2S)-3-cyclohexyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]carbamate
   Show/Hide
C32H48N4O7
 1
1 IC50 = 9 nM
CP0572027
PF-07321332
   Show/Hide
C23H32F3N5O4
 5
1 IC50 = 54 nM
2 IC50 = 75 nM
3 IC50 = 92 nM
4 Ki = 3 nM
5 Ki = 3.11 nM
CP0016253
10,11,12,13,14,16-hexazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,12,14-heptaen-8-one
   Show/Hide
C10H4N6O
 1
1 IC50 = 260 nM
CP0570967
5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide (I-1)
   Show/Hide
C20H20N2O
 3
1 IC50 = 600 nM
2 IC50 = 1390 nM
3 IC50 = 1610 nM
CP0072385
(1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione
   Show/Hide
C19H20O3
 1
1 IC50 = 4200 nM
Clinical Information about the Protein
Target 1 ( COVID-19 replicase polyprotein 1ab (pp1ab) )
Target Type Unknown Type Target
Disease 1 Target-related Disease  1
1 Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 GS-441524 Investigative
Coronavirus Disease 2019 (COVID-19)